Cargando…

Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine Streptococcus suis infection

BACKGROUND: Our previously prepared ceftiofur (CEF) hydrochloride oily suspension shows potential wide applications for controlling swine Streptococcus suis infections, while the irrational dose has not been formulated. OBJECTIVES: The rational dose regimens of CEF oily suspension against S. suis we...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Wanhe, Wang, Dehai, Qin, Hua, Chen, Dongmei, Pan, Yuanhu, Qu, Wei, Huang, Lingli, Xie, Shuyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Veterinary Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636649/
https://www.ncbi.nlm.nih.gov/pubmed/34854264
http://dx.doi.org/10.4142/jvs.2021.22.e41
_version_ 1784608570061357056
author Luo, Wanhe
Wang, Dehai
Qin, Hua
Chen, Dongmei
Pan, Yuanhu
Qu, Wei
Huang, Lingli
Xie, Shuyu
author_facet Luo, Wanhe
Wang, Dehai
Qin, Hua
Chen, Dongmei
Pan, Yuanhu
Qu, Wei
Huang, Lingli
Xie, Shuyu
author_sort Luo, Wanhe
collection PubMed
description BACKGROUND: Our previously prepared ceftiofur (CEF) hydrochloride oily suspension shows potential wide applications for controlling swine Streptococcus suis infections, while the irrational dose has not been formulated. OBJECTIVES: The rational dose regimens of CEF oily suspension against S. suis were systematically studied using a pharmacokinetic-pharmacodynamic model method. METHODS: The healthy and infected pigs were intramuscularly administered CEF hydrochloride oily suspension at a single dose of 5 mg/kg, and then the plasma and pulmonary epithelial lining fluid (PELF) were collected at different times. The minimum inhibitory concentration (MIC), minimal bactericidal concentration, mutant prevention concentration (MPC), post-antibiotic effect (PAE), and time-killing curves were determined. Subsequently, the area under the curve by the MIC (AUC(0–24h)/MIC) values of desfuroylceftiofur (DFC) in the PELF was obtained by integrating in vivo pharmacokinetic data of the infected pigs and ex vivo pharmacodynamic data using the sigmoid E(max) (Hill) equation. The dose was calculated based on the AUC(0–24h)/MIC values for bacteriostatic action, bactericidal action, and bacterial elimination. RESULTS: The peak concentration, the area under the concentration-time curve, and the time to peak for PELF's DFC were 24.76 ± 0.92 µg/mL, 811.99 ± 54.70 μg·h/mL, and 8.00 h in healthy pigs, and 33.04 ± 0.99 µg/mL, 735.85 ± 26.20 μg·h/mL, and 8.00 h in infected pigs, respectively. The MIC of PELF's DFC against S. suis strain was 0.25 µg/mL. There was strong concentration-dependent activity as determined by MPC, PAE, and the time-killing curves. The AUC(0–24h)/MIC values of PELF's DFC for bacteriostatic activity, bactericidal activity, and virtual eradication of bacteria were 6.54 h, 9.69 h, and 11.49 h, respectively. Thus, a dosage regimen of 1.94 mg/kg every 72 h could be sufficient to reach bactericidal activity. CONCLUSIONS: A rational dosage regimen was recommended, and it could assist in increasing the treatment effectiveness of CEF hydrochloride oily suspension against S. Suis infections.
format Online
Article
Text
id pubmed-8636649
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Society of Veterinary Science
record_format MEDLINE/PubMed
spelling pubmed-86366492021-12-13 Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine Streptococcus suis infection Luo, Wanhe Wang, Dehai Qin, Hua Chen, Dongmei Pan, Yuanhu Qu, Wei Huang, Lingli Xie, Shuyu J Vet Sci Original Article BACKGROUND: Our previously prepared ceftiofur (CEF) hydrochloride oily suspension shows potential wide applications for controlling swine Streptococcus suis infections, while the irrational dose has not been formulated. OBJECTIVES: The rational dose regimens of CEF oily suspension against S. suis were systematically studied using a pharmacokinetic-pharmacodynamic model method. METHODS: The healthy and infected pigs were intramuscularly administered CEF hydrochloride oily suspension at a single dose of 5 mg/kg, and then the plasma and pulmonary epithelial lining fluid (PELF) were collected at different times. The minimum inhibitory concentration (MIC), minimal bactericidal concentration, mutant prevention concentration (MPC), post-antibiotic effect (PAE), and time-killing curves were determined. Subsequently, the area under the curve by the MIC (AUC(0–24h)/MIC) values of desfuroylceftiofur (DFC) in the PELF was obtained by integrating in vivo pharmacokinetic data of the infected pigs and ex vivo pharmacodynamic data using the sigmoid E(max) (Hill) equation. The dose was calculated based on the AUC(0–24h)/MIC values for bacteriostatic action, bactericidal action, and bacterial elimination. RESULTS: The peak concentration, the area under the concentration-time curve, and the time to peak for PELF's DFC were 24.76 ± 0.92 µg/mL, 811.99 ± 54.70 μg·h/mL, and 8.00 h in healthy pigs, and 33.04 ± 0.99 µg/mL, 735.85 ± 26.20 μg·h/mL, and 8.00 h in infected pigs, respectively. The MIC of PELF's DFC against S. suis strain was 0.25 µg/mL. There was strong concentration-dependent activity as determined by MPC, PAE, and the time-killing curves. The AUC(0–24h)/MIC values of PELF's DFC for bacteriostatic activity, bactericidal activity, and virtual eradication of bacteria were 6.54 h, 9.69 h, and 11.49 h, respectively. Thus, a dosage regimen of 1.94 mg/kg every 72 h could be sufficient to reach bactericidal activity. CONCLUSIONS: A rational dosage regimen was recommended, and it could assist in increasing the treatment effectiveness of CEF hydrochloride oily suspension against S. Suis infections. The Korean Society of Veterinary Science 2021-11 2021-05-18 /pmc/articles/PMC8636649/ /pubmed/34854264 http://dx.doi.org/10.4142/jvs.2021.22.e41 Text en © 2021 The Korean Society of Veterinary Science https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Luo, Wanhe
Wang, Dehai
Qin, Hua
Chen, Dongmei
Pan, Yuanhu
Qu, Wei
Huang, Lingli
Xie, Shuyu
Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine Streptococcus suis infection
title Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine Streptococcus suis infection
title_full Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine Streptococcus suis infection
title_fullStr Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine Streptococcus suis infection
title_full_unstemmed Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine Streptococcus suis infection
title_short Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine Streptococcus suis infection
title_sort formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (pk-pd) model for treatment of swine streptococcus suis infection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636649/
https://www.ncbi.nlm.nih.gov/pubmed/34854264
http://dx.doi.org/10.4142/jvs.2021.22.e41
work_keys_str_mv AT luowanhe formulationofarationaldosageregimenofceftiofurhydrochlorideoilysuspensionbypharmacokineticpharmacodynamicpkpdmodelfortreatmentofswinestreptococcussuisinfection
AT wangdehai formulationofarationaldosageregimenofceftiofurhydrochlorideoilysuspensionbypharmacokineticpharmacodynamicpkpdmodelfortreatmentofswinestreptococcussuisinfection
AT qinhua formulationofarationaldosageregimenofceftiofurhydrochlorideoilysuspensionbypharmacokineticpharmacodynamicpkpdmodelfortreatmentofswinestreptococcussuisinfection
AT chendongmei formulationofarationaldosageregimenofceftiofurhydrochlorideoilysuspensionbypharmacokineticpharmacodynamicpkpdmodelfortreatmentofswinestreptococcussuisinfection
AT panyuanhu formulationofarationaldosageregimenofceftiofurhydrochlorideoilysuspensionbypharmacokineticpharmacodynamicpkpdmodelfortreatmentofswinestreptococcussuisinfection
AT quwei formulationofarationaldosageregimenofceftiofurhydrochlorideoilysuspensionbypharmacokineticpharmacodynamicpkpdmodelfortreatmentofswinestreptococcussuisinfection
AT huanglingli formulationofarationaldosageregimenofceftiofurhydrochlorideoilysuspensionbypharmacokineticpharmacodynamicpkpdmodelfortreatmentofswinestreptococcussuisinfection
AT xieshuyu formulationofarationaldosageregimenofceftiofurhydrochlorideoilysuspensionbypharmacokineticpharmacodynamicpkpdmodelfortreatmentofswinestreptococcussuisinfection